Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Painful Lumbar Radiculopathy
NCT00120120Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Jan 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lumbar radiculopathy comparing Lenalidomide with Placebo (2 arms). Primary endpoint: Pain Intensity Numerical Rating Scale at 12 weeks. Started Jan 2005; status: completed.
02
Drugs
lenalidomide
03
Conditions
lumbar radiculopathy
Beyond the preview
Go deeper on NCT00120120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120120.